# A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.

> **NCT01164384** · PHASE1 · UNKNOWN · sponsor: **University of Zurich**

## Conditions studied

- Chronic HCV Hepatitis C

## Interventions

- **DRUG:** Baminercept

## Key facts

- **NCT ID:** NCT01164384
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-10
- **Primary completion:** —
- **Final completion:** 2013-02
- **Target enrollment:** — (—)
- **Last updated:** 2010-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164384, "A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01164384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*